Search results
COMMENTARY: Price controls kill more than innovation
Las Vegas Review-Journal· 5 days agoIt falls under a new class of treatments called GLP-1s. The uninsured drug price is about $1,000 a month, which has raised questions by members of...
Wells Fargo Fires Employees for Faking Work By Simulating Keyboard Activity - Slashdot
Slashdot· 21 hours agoWells Fargo fired more than a dozen employees last month after investigating claims that they were faking work. From a report: The staffers, all in the firm's wealth- and investment-management ...
Six POC GOP VP Contenders
Politico· 3 days agoHer willingness to defend Syrian dictator Bashar al-Assad and her once being all in for Bernie Sanders during his 2016 presidential campaign may be a...
Primary Elections 2024: Who are Vermont's U.S. House and Senate candidates?
The Burlington Free Press· 6 days agoPrimary Elections 2024: Who are Vermont's U.S. House and Senate candidates? Vermont voters will go...
Eli Lilly exec on weight-loss drugs: 'It's not just a flash in the pan'
Yahoo Finance via AOL· 4 days agoEli Lilly may be riding high on its diabetes and weight-loss treatments Mounjaro and Zepbound —...
Flight attendants are picketing 30 U.S. airports Thursday
News 13 Orlando· 19 hours agoAirline travelers may encounter picket lines Thursday, as flight attendants worldwide hold a day of...
North Dakota voters pass measure to impose age limits on congressional candidates
NBC Universal via AOL· 2 days agoThere are currently three senators over 80: Senate Minority Leader Mitch McConnell and Sens. Chuck...
The Memo: Biden faces new Mideast crisis as tensions in Lebanon begin to boil
The Hill· 13 hours agoHostilities between Israel and Hezbollah in Lebanon are threatening to erupt into a full-scale war,...
Democrats fractured over views of pro-Palestinian campus protests, poll finds
Politico· 3 days agoOn the other hand, Republicans remain largely united in their opposition: 72 percent hold an unfavorable view of the protest encampments, building takeovers and commencement disruptions against ...
JPMorgan is getting in on the Ozempic craze with a $500 million biotech fund
Quartz· 21 hours agoAmerica’s largest bank is betting in on the craze surrounding Ozempic and other GLP-1s, a class of...